Josh Riggs, CEO and President at Oncocyte Corp (OCX), bought 3,390 shares at $2.95 ($10K) on 2024-04-11, disclosed to the SEC on 2024-04-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.